{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:53:40Z","timestamp":1794452020953,"version":"4.9.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>The 22q11.2 deletion syndrome (22q11DS) is associated with a broad spectrum of neurodevelopmental phenotypes and is the strongest known single genetic risk factor for schizophrenia. Compared to other rare structural pathogenic genetic variants, 22q11DS is relatively common and one of the most extensively studied. This review provides a state-of-the-art overview of current insights regarding associated neurodevelopmental phenotypes and potential implications for 22q11DS and beyond.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>We will first discuss recent findings with respect to neurodevelopmental phenotypic expression associated with 22q11DS, including psychotic disorders, intellectual functioning, autism spectrum disorders, as well as their interactions. Second, we will address considerations that are important in interpreting these data and propose potential implications for both the clinical care for and the empirical study of individuals with 22q11DS. Third, we will highlight variable penetrance and pleiotropy with respect to neurodevelopmental phenotypes in 22q11DS. We will discuss how these phenomena are consistently observed in the context of virtually all rare pathogenic variants and that they pose substantial challenges from both a clinical and a research perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>We outline how 22q11DS could be viewed as a genetic model for studying neurodevelopmental phenotypes. In addition, we propose that 22q11DS research can help elucidate mechanisms underlying variable expression and pleiotropy of neurodevelopmental phenotypes, insights that are likely relevant for 22q11DS and beyond, including for individuals with other rare pathogenic genetic variants and for individuals with idiopathic neurodevelopmental conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11920-021-01225-z","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T11:04:09Z","timestamp":1614164649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Neurodevelopmental Trajectories and Psychiatric Morbidity: Lessons Learned From the 22q11.2 Deletion Syndrome"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8169-7721","authenticated-orcid":false,"given":"Ania M.","family":"Fiksinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Zinkstok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Baribeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J. R. A.","family":"Chawner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A. S.","family":"Vorstman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"1225_CR1","doi-asserted-by":"crossref","unstructured":"McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JAS, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015;1:\u201315071.","DOI":"10.1038\/nrdp.2015.71"},{"key":"1225_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/adc.2003.026880","volume":"89","author":"S Oskarsd\u00f3ttir","year":"2004","unstructured":"Oskarsd\u00f3ttir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child. 2004;89:148\u201351.","journal-title":"Arch Dis Child"},{"key":"1225_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/(SICI)1096-8628(19980710)81:4<328::AID-AJMG10>3.0.CO;2-N","volume":"81","author":"AS Bassett","year":"1998","unstructured":"Bassett AS, Hodgkinson K, Chow EWC, Correia S, Scutt LE, Weksberg R. 22q11 deletion syndrome in adults with schizophrenia. Am.J.Med.Genet. 1998;81:328\u201337.","journal-title":"Am.J.Med.Genet."},{"key":"1225_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archpsyc.56.10.940","volume":"56","author":"KC Murphy","year":"1999","unstructured":"Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56:940\u20135.","journal-title":"Arch Gen Psychiatry"},{"key":"1225_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/00005053-199408000-00010","volume":"182","author":"AE Pulver","year":"1994","unstructured":"Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J.Nerv.Ment.Dis. 1994;182:476\u20138.","journal-title":"J.Nerv.Ment.Dis."},{"key":"1225_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ajmg.1320420131","volume":"42","author":"RJ Shprintzen","year":"1992","unstructured":"Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Late-onset psychosis in the velo-cardio-facial syndrome. Am.J.Med.Genet. 1992;42:141\u20132.","journal-title":"Am.J.Med.Genet."},{"key":"1225_CR7","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/ajmg.a.40387","volume":"176","author":"AM Fiksinski","year":"2018","unstructured":"\u2022 Fiksinski AM, et al. Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome. Am J Med Genet A. 2018;176:2182\u201391 One of the focuses of this review article is the detailed discussion of factors that potentially impact the prevalence rates reported for neuropsychiatric outcomes in individuals with 22q11DS. These factors include ascertainment and assessment biases, pleiotropy, age-dependency of phenotypic expression, and the frequently observed subthreshold expression of symptoms.","journal-title":"Am J Med Genet A"},{"key":"1225_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuron.2010.10.003","volume":"68","author":"PF Sullivan","year":"2010","unstructured":"Sullivan PF. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron. 2010;68:182\u20136.","journal-title":"Neuron"},{"key":"1225_CR9","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/mp.2017.161","volume":"22","author":"RE Gur","year":"2017","unstructured":"Gur RE, et al. A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium. Mol Psychiatry. 2017;22:1664\u201372.","journal-title":"Mol Psychiatry"},{"key":"1225_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","volume":"171","author":"M Schneider","year":"2014","unstructured":"Schneider M, Debban\u00e9 M, Bassett AS, Chow EWC, Fung WLA, van den Bree MBM, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014;171:627\u201339.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1225_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1192\/bjp.2018.258","volume":"215","author":"C Vingerhoets","year":"2019","unstructured":"Vingerhoets C, et al. Low prevalence of substance use in people with 22q11.2 deletion syndrome. Br J Psychiatry : the journal of mental science. 2019;215(5):661\u20137. 1\u20137.","journal-title":"Br J Psychiatry : the journal of mental science"},{"key":"1225_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41436-019-0603-1","volume":"22","author":"SL Malecki","year":"2020","unstructured":"Malecki SL, van Mil S, Graffi J, Breetvelt E, Corral M, Boot E, et al. A genetic model for multimorbidity in young adults. Gene Med : official journal of the American College of Medical Genetics. 2020;22:132\u201341.","journal-title":"Gene Med : official journal of the American College of Medical Genetics"},{"key":"1225_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1192\/bjp.bp.113.132324","volume":"204","author":"M Niarchou","year":"2014","unstructured":"Niarchou M, Zammit S, van Goozen SHM, Thapar A, Tierling HM, Owen MJ, et al. Psychopathology and cognition in children with 22q11.2 deletion syndrome. Br J Psychiatry : the journal of mental science. 2014;204:46\u201354.","journal-title":"Br J Psychiatry : the journal of mental science"},{"key":"1225_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature09552","volume":"468","author":"TR Insel","year":"2010","unstructured":"Insel TR. Rethinking schizophrenia. Nature. 2010;468:187\u201393.","journal-title":"Nature"},{"key":"1225_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamapsychiatry.2019.4779","volume":"77","author":"P Fusar-Poli","year":"2020","unstructured":"Fusar-Poli P, et al. Prevention of psychosis: advances in detection, prognosis, and intervention. JAMA Psychiatry. 2020;77:755\u201365.","journal-title":"JAMA Psychiatry"},{"key":"1225_CR16","volume-title":"The psychosis-risk syndrome: handbook for diagnosis and follow-up","author":"T McGlashan","year":"2010","unstructured":"McGlashan T, Walsh B, Woods S. The psychosis-risk syndrome: handbook for diagnosis and follow-up. New York: Oxford University Press; 2010."},{"key":"1225_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/schbul\/sbx005","volume":"43","author":"O Weisman","year":"2017","unstructured":"Weisman O, Guri Y, Gur RE, McDonald-McGinn DM, Calkins ME, Tang SX, et al. Subthreshold psychosis in 22q11.2 deletion syndrome: multisite naturalistic study. Schizophr Bull. 2017;43:1079\u201389.","journal-title":"Schizophr Bull"},{"key":"1225_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11920-008-0026-1","volume":"10","author":"AS Bassett","year":"2008","unstructured":"Bassett AS, Chow EW. Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep. 2008;10:148\u201357.","journal-title":"Curr Psychiatry Rep"},{"key":"1225_CR19","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1176\/appi.ajp.160.9.1580","volume":"160","author":"AS Bassett","year":"2003","unstructured":"Bassett AS, Chow EWC, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry. 2003;160:1580\u20136.","journal-title":"Am J Psychiatry"},{"key":"1225_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.schres.2014.01.020","volume":"153","author":"S Monks","year":"2014","unstructured":"Monks S, Niarchou M, Davies AR, Walters JTR, Williams N, Owen MJ, et al. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. Schizophr Res. 2014;153:231\u20136.","journal-title":"Schizophr Res"},{"key":"1225_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.schres.2012.04.020","volume":"139","author":"M Armando","year":"2012","unstructured":"Armando M, Girardi P, Vicari S, Menghini D, Digilio MC, Pontillo M, et al. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning. Schizophr Res. 2012;139:151\u20136.","journal-title":"Schizophr Res"},{"key":"1225_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.schres.2016.12.023","volume":"188","author":"E Mekori-Domachevsky","year":"2017","unstructured":"Mekori-Domachevsky E, Guri Y, Yi J, Weisman O, Calkins ME, Tang SX, et al. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: a two-site study. Schizophr Res. 2017;188:42\u20139.","journal-title":"Schizophr Res"},{"key":"1225_CR23","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1017\/S0033291713001669","volume":"44","author":"SX Tang","year":"2014","unstructured":"Tang SX, Yi JJ, Calkins ME, Whinna DA, Kohler CG, Souders MC, et al. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychol Med. 2014;44:1267\u201377.","journal-title":"Psychol Med"},{"issue":"Suppl 1","key":"1225_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4088\/JCP.13049su1c.04","volume":"75","author":"L Citrome","year":"2014","unstructured":"Citrome L. Unmet needs in the treatment of schizophrenia: new targets to help different symptom domains. J Clin Psychiatry. 2014;75(Suppl 1):21\u20136.","journal-title":"J Clin Psychiatry"},{"key":"1225_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.schres.2018.10.014","volume":"206","author":"M Schneider","year":"2019","unstructured":"Schneider M, Armando M, Schultze-Lutter F, Pontillo M, Vicari S, Debban\u00e9 M, et al. Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome. Schizophr Res. 2019;206:386\u201393.","journal-title":"Schizophr Res"},{"key":"1225_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/wps.20347","volume":"15","author":"M Schneider","year":"2016","unstructured":"Schneider M, Armando M, Pontillo M, Vicari S, Debban\u00e9 M, Schultze-Lutter F, et al. Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome. World Psychiatry : official journal of the World Psychiatric Association. 2016;15:259\u201365.","journal-title":"World Psychiatry : official journal of the World Psychiatric Association"},{"key":"1225_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","volume":"70","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-R\u00f6ssler A, Schultze-Lutter F, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70:107\u201320.","journal-title":"JAMA Psychiatry"},{"key":"1225_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jamapsychiatry.2016.3939","volume":"74","author":"LK Hoeffding","year":"2017","unstructured":"Hoeffding LK, Trabjerg BB, Olsen L, Mazin W, Spars\u00f8 T, Vangkilde A, et al. Risk of psychiatric disorders among individuals with the 22q11.2 deletion or duplication: a Danish nationwide, register-based study. JAMA psychiatry. 2017;74:282\u201390.","journal-title":"JAMA psychiatry"},{"key":"1225_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","volume":"171","author":"M Schneider","year":"2014","unstructured":"Schneider M, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014;171:627\u201339.","journal-title":"Am J Psychiatry"},{"key":"1225_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaac.2015.03.016","volume":"54","author":"DA Baribeau","year":"2015","unstructured":"Baribeau DA, et al. Examining and comparing social perception abilities across childhood-onset neurodevelopmental disorders. J Am Acad Child Adolesc Psychiatry. 2015;54:479\u2013486 e471.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1225_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13229-020-00338-1","volume":"11","author":"AD Krakowski","year":"2020","unstructured":"Krakowski AD, Cost KT, Anagnostou E, Lai MC, Crosbie J, Schachar R, et al. Inattention and hyperactive\/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit\/hyperactivity disorder in a clinical sample. Mol Autism. 2020;11:28.","journal-title":"Mol Autism"},{"key":"1225_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00787-010-0092-x","volume":"19","author":"NN Rommelse","year":"2010","unstructured":"Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK. Shared heritability of attention-deficit\/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry. 2010;19:281\u201395.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1225_CR33","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/01.chi.0000228131.56956.c1","volume":"45","author":"JAS Vorstman","year":"2006","unstructured":"Vorstman JAS, et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry. 2006;45:1104\u201313.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1225_CR34","unstructured":"Chawner, S., et al. A genetics-first approach to dissecting the heterogeneity of autism: phenotypic comparison of autism risk copy number variants. medRxiv, 2020.2001.2014.20017426 (2020)."},{"key":"1225_CR35","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1176\/appi.ajp.2009.09071016","volume":"167","author":"AS Bassett","year":"2010","unstructured":"Bassett AS, Scherer SW, Brzustowicz LM. Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry. 2010;167:899\u2013914.","journal-title":"Am J Psychiatry"},{"key":"1225_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WCO.0b013e32835f1a30","volume":"26","author":"JA Vorstman","year":"2013","unstructured":"Vorstman JA, Ophoff RA. Genetic causes of developmental disorders. Curr Opin Neurol. 2013;26:128\u201336.","journal-title":"Curr Opin Neurol"},{"key":"1225_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/WCO.0b013e328352dd58","volume":"25","author":"K Baker","year":"2012","unstructured":"Baker K, Vorstman JA. Is there a core neuropsychiatric phenotype in 22q11.2 deletion syndrome? Curr Opin Neurol. 2012;25:131\u20137.","journal-title":"Curr Opin Neurol"},{"key":"1225_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/gm546","volume":"6","author":"JL Doherty","year":"2014","unstructured":"Doherty JL, Owen MJ. Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med. 2014;6:29.","journal-title":"Genome Med"},{"key":"1225_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11689-019-9267-z","volume":"11","author":"Z Motahari","year":"2019","unstructured":"Motahari Z, Moody SA, Maynard TM, LaMantia AS. In the line-up: deleted genes associated with DiGeorge\/22q11.2 deletion syndrome: are they all suspects? J Neurodev Disord. 2019;11:7.","journal-title":"J Neurodev Disord"},{"key":"1225_CR40","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1093\/hmg\/ddz166","volume":"28","author":"L Vervoort","year":"2019","unstructured":"Vervoort L, Demaerel W, Rengifo LY, Odrzywolski A, Vergaelen E, Hestand MS, et al. Atypical chromosome 22q11.2 deletions are complex rearrangements and have different mechanistic origins. Hum Mol Genet. 2019;28:3724\u201333.","journal-title":"Hum Mol Genet"},{"key":"1225_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000438708","volume":"146","author":"RD Burnside","year":"2015","unstructured":"Burnside RD. 22q11.21 deletion syndromes: a review of proximal, central, and distal deletions and their associated features. Cytogenet Genome Res. 2015;146:89\u201399.","journal-title":"Cytogenet Genome Res"},{"key":"1225_CR42","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/hmg\/ddy028","volume":"27","author":"T Guo","year":"2018","unstructured":"Guo T, Diacou A, Nomaru H, McDonald-McGinn DM, Hestand M, Demaerel W, et al. Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2. Hum Mol Genet. 2018;27:1150\u201363.","journal-title":"Hum Mol Genet"},{"key":"1225_CR43","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/ajmg.a.40359","volume":"176","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, et al. Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects. Am J Med Genet A. 2018;176:2172\u201381.","journal-title":"Am J Med Genet A"},{"key":"1225_CR44","unstructured":"Ching CRK, et al. Mapping subcortical brain alterations in 22q11.2 deletion syndrome: effects of deletion size and convergence with idiopathic neuropsychiatric illness. appiajp201919060583 (2020)."},{"key":"1225_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41398-018-0354-9","volume":"9","author":"E Michaelovsky","year":"2019","unstructured":"Michaelovsky E, et al. Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach. Transl Psychiatry. 2019;9:15.","journal-title":"Transl Psychiatry"},{"key":"1225_CR46","doi-asserted-by":"publisher","first-page":"e0173944","DOI":"10.1371\/journal.pone.0173944","volume":"12","author":"NJ Butcher","year":"2017","unstructured":"Butcher NJ, et al. Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson\u2019s disease. PLoS One. 2017;12:e0173944.","journal-title":"PLoS One"},{"key":"1225_CR47","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1176\/appi.ajp.2017.16121417","volume":"174","author":"AS Bassett","year":"2017","unstructured":"Bassett AS, Lowther C, Merico D, Costain G, Chow EWC, van Amelsvoort T, et al. Rare genome-wide copy number variation and expression of schizophrenia in 22q11.2 deletion syndrome. Am J Psychiatry. 2017;174:1054\u201363.","journal-title":"Am J Psychiatry"},{"key":"1225_CR48","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/ajmg.a.40494","volume":"176","author":"JL Cohen","year":"2018","unstructured":"Cohen JL, Crowley TB, McGinn DE, McDougall C, Unolt M, Lambert MP, et al. 22q and two: 22q11.2 deletion syndrome and coexisting conditions. Am J Med Genet A. 2018;176:2203\u201314.","journal-title":"Am J Med Genet A"},{"key":"1225_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0566-4","volume":"562","author":"MEK Niemi","year":"2018","unstructured":"Niemi MEK, Martin HC, Rice DL, Gallone G, Gordon S, Kelemen M, et al. Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature. 2018;562:268\u201371.","journal-title":"Nature"},{"key":"1225_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jamapsychiatry.2018.0039","volume":"75","author":"G Huguet","year":"2018","unstructured":"Huguet G, Schramm C, Douard E, Jiang L, Labbe A, Tihy F, et al. Measuring and estimating the effect sizes of copy number variants on general intelligence in community-based samples. JAMA Psychiatry. 2018;75:447\u201357.","journal-title":"JAMA Psychiatry"},{"key":"1225_CR51","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S2215-0366(19)30123-3","volume":"6","author":"S Chawner","year":"2019","unstructured":"\u2022 Chawner S, et al. Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study. Lancet Psychiatry. 2019;6:493\u2013505 This case-control study studied neurodevelopmental phenotypes in children with one of the 13 different copy number variants (CNVs). There were subtle quantitative and qualitative differences in the impact on neurodevelopment between the CNVs. Importantly, the risk for neuropsychiatric outcomes conferred by the CNVs was pleiotropic, affecting multiple neurodevelopmental processes and underlining that different neurodevelopmental phenotypes should be studied synergistically, rather than merely as entirely independent constructs.","journal-title":"Lancet Psychiatry"},{"key":"1225_CR52","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1534\/g3.115.021345","volume":"5","author":"D Merico","year":"2015","unstructured":"Merico D, et al. Whole-genome sequencing suggests schizophrenia risk mechanisms in humans with 22q11.2 deletion syndrome. G3 (Bethesda). 2015;5:2453\u201361.","journal-title":"G3 (Bethesda)"},{"key":"1225_CR53","unstructured":"\u2022 Cleynen I, et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Mol Psychiatry (2020). This study used whole-genome sequencing data from 519 unrelated individuals with 22q11DS. Findings revealed, for the first time, that the polygenic score for schizophrenia was elevated in the individual with 22q11DS and schizophrenia, as compared to individuals with 22q11DS but not psychotic illness. Thus, in addition to the deletion conferring a substantially increased risk for schizophrenia in these individuals, the risk is further elevated by common polygenic risk factors that contribute to schizophrenia in the general population."},{"key":"1225_CR54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1176\/appi.ajp.2019.19080825","volume":"176","author":"EB Binder","year":"2019","unstructured":"Binder EB. Polygenic risk scores in schizophrenia: ready for the real world? Am J Psychiatry. 2019;176:783\u20134.","journal-title":"Am J Psychiatry"},{"key":"1225_CR55","unstructured":"\u2022 Murray GK, Lin T, Austin J, McGrath JJ, Hickie IB, Wray NR Could polygenic risk scores be useful in psychiatry?: a review. JAMA Psychiatry (2020). This review discussed the potential use of polygenic risk scores in psychiatry and elaborates on important associated considerations. One of the main conclusions is that, when combined with information from molecular, clinical, and lifestyle metrics, polygenic scores will likely contribute to risk assessment in clinical psychiatry. The importance of considering such advances in an ethical framework as well as in the context of realistic expectations is highlighted."},{"key":"1225_CR56","unstructured":"\u2022 Davies RW, et al. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. Nature Medicine, in press (2020). This study of 962 individuals with 22q11DS demonstrated that common genetic variation associated with schizophrenia and IQ in the general population impacts expression of these respective phenotypes in the context of a 22q11.2 deletion as well, informing on the mechanisms underlying the observed variable penetrance of these phenotypes. Further, the findings revealed that polygenic scores for schizophrenia and IQ can be used to substantially improve risk stratification in the context of the presence of a high-impact genetic variant that is associated with an a priori elevanted risk for these phenotypes."},{"key":"1225_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fneur.2014.00238","volume":"5","author":"D Merico","year":"2014","unstructured":"Merico D, et al. MicroRNA dysregulation, gene networks, and risk for schizophrenia in 22q11.2 deletion syndrome. Front Neurol. 2014;5:238.","journal-title":"Front Neurol"},{"key":"1225_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/mp.2016.150","volume":"22","author":"E Mahmoudi","year":"2017","unstructured":"Mahmoudi E, Cairns MJ. MiR-137: an important player in neural development and neoplastic transformation. Mol Psychiatry. 2017;22:44\u201355.","journal-title":"Mol Psychiatry"},{"key":"1225_CR59","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1253895","volume":"344","author":"S Chun","year":"2014","unstructured":"Chun S, Westmoreland JJ, Bayazitov IT, Eddins D, Pani AK, Smeyne RJ, et al. Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models. Science. 2014;344:1178\u201382.","journal-title":"Science"},{"key":"1225_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nm.4240","volume":"23","author":"S Chun","year":"2017","unstructured":"Chun S, du F, Westmoreland JJ, Han SB, Wang YD, Eddins D, et al. Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion. Nat Med. 2017;23:39\u201348.","journal-title":"Nat Med"},{"key":"1225_CR61","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41467-020-14628-y","volume":"11","author":"TY Eom","year":"2020","unstructured":"Eom TY, Han SB, Kim J, Blundon JA, Wang YD, Yu J, et al. Schizophrenia-related microdeletion causes defective ciliary motility and brain ventricle enlargement via microRNA-dependent mechanisms in mice. Nat Commun. 2020;11:912.","journal-title":"Nat Commun"},{"key":"1225_CR62","doi-asserted-by":"publisher","first-page":"S525","DOI":"10.1093\/schbul\/sby025","volume":"44","author":"M Armando","year":"2018","unstructured":"Armando M, Sandini C, Chambaz M, Schaer M, Schneider M, Eliez S. Coping strategies mediate the effect of stressful life events on schizotypal traits and psychotic symptoms in 22q11.2 deletion syndrome. Schizophr Bull. 2018;44:S525\u201335.","journal-title":"Schizophr Bull"},{"key":"1225_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jpsychires.2019.04.011","volume":"114","author":"D Mayo","year":"2019","unstructured":"Mayo D, Bolden KA, Simon TJ, Niendam TA. Bullying and psychosis: the impact of chronic traumatic stress on psychosis risk in 22q11.2 deletion syndrome - a uniquely vulnerable population. J Psychiatr Res. 2019;114:99\u2013104.","journal-title":"J Psychiatr Res"},{"key":"1225_CR64","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/npjschz.2016.3","volume":"2","author":"IE Sommer","year":"2016","unstructured":"Sommer IE, Bearden CE, van Dellen E, Breetvelt EJ, Duijff SN, Maijer K, et al. Early interventions in risk groups for schizophrenia: what are we waiting for? NPJ Schizophr. 2016;2:16003.","journal-title":"NPJ Schizophr"},{"key":"1225_CR65","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/ajmg.a.38500","volume":"176","author":"S Tang","year":"2017","unstructured":"Tang S, Gur R. Longitudinal perspectives on the psychosis spectrum in 22q11. 2 deletion syndrome. Am J Med Genet A. 2017;176:2192\u2013202.","journal-title":"Am J Med Genet A"},{"key":"1225_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/pd.4935","volume":"37","author":"AS Bassett","year":"2017","unstructured":"Bassett AS, Costain G, Marshall CR. Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting. Prenat Diagn. 2017;37:61\u20139.","journal-title":"Prenat Diagn"},{"key":"1225_CR67","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/ajmg.a.38665","volume":"176","author":"E Schindewolf","year":"2018","unstructured":"Schindewolf E, Khalek N, Johnson MP, Gebb J, Coleman B, Crowley TB, et al. Expanding the fetal phenotype: prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome. Am J Med Genet A. 2018;176:1735\u201341.","journal-title":"Am J Med Genet A"},{"key":"1225_CR68","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fpsyt.2020.00646","volume":"11","author":"C Sandini","year":"2020","unstructured":"Sandini C, Schneider M, Eliez S, Armando M. Association between parental anxiety and depression level and psychopathological symptoms in offspring with 22q11.2 deletion syndrome. Front Psychiatry. 2020;11:646.","journal-title":"Front Psychiatry"},{"key":"1225_CR69","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamapsychiatry.2014.2671","volume":"72","author":"JA Vorstman","year":"2015","unstructured":"Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA psychiatry. 2015;72:377\u201385.","journal-title":"JAMA psychiatry"},{"key":"1225_CR70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1192\/bjp.bp.116.195651","volume":"211","author":"SJ Chawner","year":"2017","unstructured":"Chawner SJ, et al. Childhood cognitive development in 22q11. 2 deletion syndrome: case\u2013control study. Br J Psychiatry. 2017;211:223\u201330. bjp. bp. 116.195651.","journal-title":"Br J Psychiatry"},{"key":"1225_CR71","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1076\/0929-7049(199912)05:04;1-R;FT230","volume":"5","author":"A Swillen","year":"1999","unstructured":"Swillen A, Vandeputte L, Cracco J, Maes B, Ghesqui\u00e8re P, Devriendt K, et al. Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? Child Neuropsychol. 1999;5:230\u201341.","journal-title":"Child Neuropsychol"},{"key":"1225_CR72","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.schres.2006.04.007","volume":"87","author":"EW Chow","year":"2006","unstructured":"Chow EW, Watson M, Young DA, Bassett AS. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res. 2006;87:270\u20138.","journal-title":"Schizophr Res"},{"key":"1225_CR73","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1365-2788.2007.00955.x","volume":"51","author":"B De Smedt","year":"2007","unstructured":"De Smedt B, et al. Intellectual abilities in a large sample of children with velo-cardio-facial syndrome: an update. J Intellect Disabil Res. 2007;51:666\u201370.","journal-title":"J Intellect Disabil Res"},{"key":"1225_CR74","doi-asserted-by":"crossref","unstructured":"Wechsler D Wechsler adult intelligence scale\u20134th edition., (Pearson, San Antonio 2008).","DOI":"10.1037\/t15169-000"},{"key":"1225_CR75","doi-asserted-by":"crossref","unstructured":"Fiksinski AM, Bearden CE, Bassett AS, Kahn RS, Zinkstok JR, Hooper SR, et al. The 22q11DS international consortium on brain and behavior. In Vorstman JAS, Breetvelt EJ (eds.). A normative chart for cognitive development in a genetically selected population. Neuropsychopharmacology. 2021.","DOI":"10.1038\/s41386-021-00988-6"},{"key":"1225_CR76","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/mp.2014.105","volume":"20","author":"R Plomin","year":"2015","unstructured":"Plomin R, Deary IJ. Genetics and intelligence differences: five special findings. Mol Psychiatry. 2015;20:98\u2013108.","journal-title":"Mol Psychiatry"},{"key":"1225_CR77","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/ajmg.b.32441","volume":"171","author":"P Klaassen","year":"2016","unstructured":"Klaassen P, Duijff S, Swanenburg de Veye H, Beemer F, Sinnema G, Breetvelt E, et al. Explaining the variable penetrance of CNVs: parental intelligence modulates expression of intellectual impairment caused by the 22q11.2 deletion. Am J Med Gen Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2016;171:790\u20136.","journal-title":"Am J Med Gen Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics"},{"key":"1225_CR78","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.ridd.2014.08.034","volume":"35","author":"AK Olszewski","year":"2014","unstructured":"Olszewski AK, Radoeva PD, Fremont W, Kates WR, Antshel KM. Is child intelligence associated with parent and sibling intelligence in individuals with developmental disorders? An investigation in youth with 22q112 deletion (velo-cardio-facial) syndrome. Res Dev Disabil. 2014;35:3582\u201390.","journal-title":"Res Dev Disabil"},{"key":"1225_CR79","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1001\/jamapsychiatry.2014.2147","volume":"72","author":"A Moreno-De-Luca","year":"2015","unstructured":"Moreno-De-Luca A, et al. The role of parental cognitive, behavioral, and motor profiles in clinical variability in individuals with chromosome 16p11.2 deletions. JAMA Psychiatry. 2015;72:119\u201326.","journal-title":"JAMA Psychiatry"},{"key":"1225_CR80","doi-asserted-by":"crossref","unstructured":"Fiksinski AM, Heung T, Corral M, Breetvelt EJ, Costain G, Marshall CR, et al. Within-family influences on dimensional neurobehavioral traits in a high-risk genetic model. Psychological Medicine. 2021; 1\u20139.","DOI":"10.1017\/S0033291720005279"},{"key":"1225_CR81","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1038\/s41467-018-04362-x","volume":"9","author":"G Davies","year":"2018","unstructured":"Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018;9:2098.","journal-title":"Nat Commun"},{"key":"1225_CR82","first-page":"307","volume":"20","author":"LJ Evers","year":"2009","unstructured":"Evers LJ, De Die-Smulders CE, Smeets EE, Clerkx MG, Curfs LM. The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at adult age. Genet Couns. 2009;20:307\u201315.","journal-title":"Genet Couns"},{"key":"1225_CR83","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1192\/bjp.bp.111.097139","volume":"200","author":"SN Duijff","year":"2012","unstructured":"Duijff SN, Klaassen PWJ, de Veye HFNS, Beemer FA, Sinnema G, Vorstman JAS. Cognitive development in children with 22q11.2 deletion syndrome. Br J Psychiatry : the journal of mental science. 2012;200:462\u20138.","journal-title":"Br J Psychiatry : the journal of mental science"},{"key":"1225_CR84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ajmg.c.31435","volume":"169","author":"A Swillen","year":"2015","unstructured":"Swillen A, McDonald-McGinn D. Developmental trajectories in 22q11.2 deletion. Am J Med Genet C: Semin Med Genet. 2015;169:172\u201381.","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"1225_CR85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/2013.jamapsychiatry.43","volume":"70","author":"JH MacCabe","year":"2013","unstructured":"MacCabe JH, Wicks S, L\u00f6fving S, David AS, Berndtsson \u00c5, Gustafsson JE, et al. Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthood: a Swedish longitudinal cohort study in males. JAMA Psychiatry. 2013;70:261\u201370.","journal-title":"JAMA Psychiatry"},{"key":"1225_CR86","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1001\/jamapsychiatry.2017.4327","volume":"75","author":"J Mollon","year":"2018","unstructured":"Mollon J, David AS, Zammit S, Lewis G, Reichenberg A. Course of cognitive development from infancy to early adulthood in the psychosis spectrum. JAMA Psychiatry. 2018;75:270\u20139.","journal-title":"JAMA Psychiatry"},{"key":"1225_CR87","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11920-996-0038-7","volume":"3","author":"PD Harvey","year":"2001","unstructured":"Harvey PD, Bowie CR, Friedman JI. Cognition in schizophrenia. Curr Psychiatry Rep. 2001;3:423\u20138.","journal-title":"Curr Psychiatry Rep"},{"key":"1225_CR88","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jamapsychiatry.2017.0312","volume":"74","author":"RSE Keefe","year":"2017","unstructured":"Keefe RSE, Kahn RS. Cognitive decline and disrupted cognitive trajectory in schizophrenia. JAMA Psychiatry. 2017;74:535\u20136.","journal-title":"JAMA Psychiatry"},{"key":"1225_CR89","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","volume":"70","author":"RS Kahn","year":"2013","unstructured":"Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70:1107\u201312.","journal-title":"JAMA Psychiatry"},{"key":"1225_CR90","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1176\/appi.ajp.2019.19050527","volume":"177","author":"D Dickinson","year":"2019","unstructured":"Dickinson D, et al. Distinct polygenic score profiles in schizophrenia subgroups with different trajectories of cognitive development. Am J Psychiatry. 2019;177:298\u2013307, appiajp201919050527.","journal-title":"Am J Psychiatry"},{"key":"1225_CR91","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/13668250.2011.572548","volume":"36","author":"SL Einfeld","year":"2011","unstructured":"Einfeld SL, Ellis LA, Emerson E. Comorbidity of intellectual disability and mental disorder in children and adolescents: a systematic review. J Intellect Dev Disabil. 2011;36:137\u201343.","journal-title":"J Intellect Dev Disabil"},{"key":"1225_CR92","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/jir.12117","volume":"58","author":"LJ Evers","year":"2014","unstructured":"Evers LJ, et al. Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability. J Intellect Disabil Res. 2014;58:915\u201325.","journal-title":"J Intellect Disabil Res"},{"key":"1225_CR93","doi-asserted-by":"crossref","unstructured":"Morrison S, et al. Cognitive deficits in childhood, adolescence and adulthood in 22q11.2 deletion syndrome and association with psychopathology. Transl Psychiatry. 2020;10(53).","DOI":"10.1038\/s41398-020-0736-7"},{"key":"1225_CR94","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jpeds.2011.02.039","volume":"159","author":"AS Bassett","year":"2011","unstructured":"Bassett AS, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159:332\u2013339 e331.","journal-title":"J Pediatr"},{"key":"1225_CR95","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jpsychires.2014.03.021","volume":"54","author":"A Millier","year":"2014","unstructured":"Millier A, Schmidt U, Angermeyer MC, Chauhan D, Murthy V, Toumi M, et al. Humanistic burden in schizophrenia: a literature review. J Psychiatr Res. 2014;54:85\u201393.","journal-title":"J Psychiatr Res"},{"key":"1225_CR96","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/schbul\/sbv023","volume":"42","author":"M Davidson","year":"2016","unstructured":"Davidson M, Kapara O, Goldberg S, Yoffe R, Noy S, Weiser M. A nation-wide study on the percentage of schizophrenia and bipolar disorder patients who earn minimum wage or above. Schizophr Bull. 2016;42:443\u20137.","journal-title":"Schizophr Bull"},{"key":"1225_CR97","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","volume":"4","author":"C Hjorthoj","year":"2017","unstructured":"Hjorthoj C, Sturup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4:295\u2013301.","journal-title":"Lancet Psychiatry"},{"key":"1225_CR98","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0006-3223(99)00114-6","volume":"46","author":"AS Bassett","year":"1999","unstructured":"Bassett AS, Chow EW. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol.Psychiatry. 1999;46:882\u201391.","journal-title":"Biol.Psychiatry"},{"key":"1225_CR99","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.physrep.2005.10.009","volume":"424","author":"S Boccaletti","year":"2006","unstructured":"Boccaletti S, Latora V, Moreno Y, Chavez M, Hwang DU. Complex networks: structure and dynamics. Phys Rep. 2006;424:175\u2013308.","journal-title":"Phys Rep"},{"key":"1225_CR100","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0145445503259830","volume":"28","author":"KS Rush","year":"2004","unstructured":"Rush KS, Bowman LG, Eidman SL, Toole LM, Mortenson BP. Assessing psychopathology in individuals with developmental disabilities. Behav Modif. 2004;28:621\u201337.","journal-title":"Behav Modif"},{"key":"1225_CR101","first-page":"567","volume":"86","author":"S Reiss","year":"1982","unstructured":"Reiss S, Levitan GW, Szyszko J. Emotional disturbance and mental retardation: diagnostic overshadowing. Am J Ment Defic. 1982;86:567\u201374.","journal-title":"Am J Ment Defic"},{"key":"1225_CR102","doi-asserted-by":"crossref","unstructured":"American_Psychiatric_Association & DSM_Task_Force. Diagnostic and statistical manual of mental disorders : DSM-5. (2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1225_CR103","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1176\/appi.ajp.2008.07081242","volume":"165","author":"KA Woodberry","year":"2008","unstructured":"Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry. 2008;165:579\u201387.","journal-title":"Am J Psychiatry"},{"key":"1225_CR104","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/appi.ajp.2009.09040574","volume":"167","author":"A Reichenberg","year":"2010","unstructured":"Reichenberg A, Caspi A, Harrington HL, Houts R, Keefe RSE, Murray RM, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry. 2010;167:160\u20139.","journal-title":"Am J Psychiatry"},{"key":"1225_CR105","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cell.2012.02.039","volume":"148","author":"D Malhotra","year":"2012","unstructured":"Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148:1223\u201341.","journal-title":"Cell"},{"key":"1225_CR106","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0022-3476(65)82145-X","volume":"67","author":"A DiGeorge","year":"1965","unstructured":"DiGeorge A. A new concept of the cellular base of immunology. J Pediatr. 1965;67:907\u20138.","journal-title":"J Pediatr"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-021-01225-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-021-01225-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-021-01225-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T01:36:46Z","timestamp":1619401006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-021-01225-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1225"],"URL":"https:\/\/doi.org\/10.1007\/s11920-021-01225-z","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"13 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jacob A.S. Vorstman serves as a consultant for NoBias Therapeutics Inc. for the design of a medication trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"13"}}